UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002900 |
|---|---|
| Receipt number | R000003538 |
| Scientific Title | A Phase I/II study of Pemetrexed plus Erlotinib therapy in Previously Treated Non-Small-Cell Lung Cancer. |
| Date of disclosure of the study information | 2009/12/15 |
| Last modified on | 2012/12/15 22:03:23 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/12/15 17:59:43 | ||
| 2 | Update | 2010/06/15 09:39:02 | Last name of lead principal investigator Last name of lead principal investigator |
|
| 3 | Update | 2011/12/15 15:47:20 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2012/12/15 22:03:24 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
